Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Nov 24 | VRCA Verrica Pharmaceuticals | Common Stock | Gift | Acquire G | No | No | 0 | 50,000 | 0.00 | 1,873,800 |
22 Nov 24 | VRCA Verrica Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 0 | 1,123,595 | 0.00 | 1,823,800 |
22 Nov 24 | VRCA Verrica Pharmaceuticals | Series B Warrants Common Stock | Buy | Acquire P | No | No | 1.335 | 561,797 | 750.00 k | 561,797 |
22 Nov 24 | VRCA Verrica Pharmaceuticals | Series A Warrants Common Stock | Buy | Acquire P | No | No | 1.068 | 561,797 | 600.00 k | 561,797 |
10 Jun 24 | ABOS Acumen Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.62 | 25,000 | 65.50 k | 25,000 |
29 May 24 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 49,220 | 0.00 | 1,098,601 |
29 May 24 | TSHA Taysha Gene Therapies | Stock Option Common Stock | Grant | Acquire A | No | No | 3.17 | 98,440 | 312.05 k | 98,440 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Gift | Acquire G | No | No | 0 | 50,000 | 0.00 | 1,049,381 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | No | No | 0.9 | 388,889 | 350.00 k | 999,381 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 0.9 | 388,889 | 350.00 k | 884,290 |